|
|
Article: Fundamental Review for SIGA Technologies Inc.
- Article from:
- M2 Presswire
- Article date:
- December 27, 2006
CopyrightCOPYRIGHT 2006 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-27 December 2006-Biotech News: Fundamental Review for SIGA Technologies Inc(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:27122006
Fundamental Review for SIGA Technologies Inc (NASDAQ:SIGA)
Say "ahhh" instead of "ow!" If development-stage SIGA Technologies has its way, painful vaccinations could become a thing of the past. The company is working on technology to administer vaccines directly through the mucus-lined surfaces -- mouth, nose, lungs, and gastrointestinal and urogenital tracts -- that are the usual entry points for most infectious agents. It focuses on vaccines, novel anti-infectives, and antibiotics for infectious diseases; ...